AU540859B2 - L-carnitine and l-acylcarniture compositions - Google Patents

L-carnitine and l-acylcarniture compositions

Info

Publication number
AU540859B2
AU540859B2 AU70486/81A AU7048681A AU540859B2 AU 540859 B2 AU540859 B2 AU 540859B2 AU 70486/81 A AU70486/81 A AU 70486/81A AU 7048681 A AU7048681 A AU 7048681A AU 540859 B2 AU540859 B2 AU 540859B2
Authority
AU
Australia
Prior art keywords
acylcarniture
carnitine
compositions
acylcarniture compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU70486/81A
Other languages
English (en)
Other versions
AU7048681A (en
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU7048681A publication Critical patent/AU7048681A/en
Application granted granted Critical
Publication of AU540859B2 publication Critical patent/AU540859B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU70486/81A 1980-05-15 1981-05-12 L-carnitine and l-acylcarniture compositions Expired AU540859B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4869280 1980-05-15
IT48692/80A IT1133010B (it) 1980-05-15 1980-05-15 Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo

Publications (2)

Publication Number Publication Date
AU7048681A AU7048681A (en) 1981-11-26
AU540859B2 true AU540859B2 (en) 1984-12-06

Family

ID=11268073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70486/81A Expired AU540859B2 (en) 1980-05-15 1981-05-12 L-carnitine and l-acylcarniture compositions

Country Status (14)

Country Link
US (1) US4362719A (fr)
JP (1) JPS579721A (fr)
AU (1) AU540859B2 (fr)
BE (1) BE888797A (fr)
CA (1) CA1173749A (fr)
CH (1) CH654208A5 (fr)
DE (1) DE3119460A1 (fr)
FR (1) FR2482588B1 (fr)
GB (1) GB2075838B (fr)
IE (1) IE51224B1 (fr)
IL (1) IL62847A (fr)
IT (1) IT1133010B (fr)
NL (1) NL8102384A (fr)
SE (1) SE8103003L (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
IT1237343B (it) * 1984-03-28 1993-05-31 Francia Farma Dicloridrato di acetildicarnitina, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
DE3635864A1 (de) * 1986-06-26 1988-05-05 Gerhard Gergely Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5321009A (en) * 1991-04-03 1994-06-14 American Home Products Corporation Method of treating diabetes
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
MA26553A1 (fr) * 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
AU2002253857A1 (en) * 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
KR20100017460A (ko) * 2007-05-24 2010-02-16 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 피피에이알 감마 작용물질로 인한 부작용의 예방에 유용한 조성물
CN107121540B (zh) * 2016-02-24 2020-06-12 中国科学院上海营养与健康研究所 酰基肉碱谱或其检测试剂在2型糖尿病发病风险预测中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
JPS5058213A (fr) * 1973-09-26 1975-05-21
FR2414914A1 (fr) * 1978-01-18 1979-08-17 Sigma Tau Ind Farmaceuti Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Also Published As

Publication number Publication date
SE8103003L (sv) 1981-11-16
DE3119460A1 (de) 1982-03-04
IL62847A (en) 1985-01-31
JPS579721A (en) 1982-01-19
FR2482588A1 (fr) 1981-11-20
FR2482588B1 (fr) 1986-03-07
BE888797A (fr) 1981-08-28
CA1173749A (fr) 1984-09-04
IE51224B1 (en) 1986-11-12
CH654208A5 (it) 1986-02-14
AU7048681A (en) 1981-11-26
GB2075838A (en) 1981-11-25
IT8048692A0 (it) 1980-05-15
US4362719A (en) 1982-12-07
NL8102384A (nl) 1981-12-01
GB2075838B (en) 1984-05-10
IT1133010B (it) 1986-07-09
IE811011L (en) 1981-11-15
IL62847A0 (en) 1981-07-31

Similar Documents

Publication Publication Date Title
AU555915B2 (en) Lipip compositions
AU549328B2 (en) Modified ionomer and application thereof
AU545004B2 (en) Antigingivites composition
AU540859B2 (en) L-carnitine and l-acylcarniture compositions
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
AU7347681A (en) Acylmuramyl and acyldesmethylmuramyl dipeptides
AU1147783A (en) Rtv-organdpolysiloxane composition
DE3169284D1 (en) Etchant composition and application thereof
AU560418B2 (en) Mothproofing and beetleproofing composition
AU528710B2 (en) Hexahydro-trans and tetrahydropyridoindole
AU7540681A (en) Isocyanate-unsaturated polyester compositions
AU524882B2 (en) Carbapenams and carbapen-2-ems
AU7238581A (en) Tylactone and esters thereof
AU556553B2 (en) Composition
AU1898983A (en) Perfluoroalkylmaleinamides and perfluoroalkylfumaramides
AU7701981A (en) Anaerosically-curing compositions
AU537113B2 (en) Hydroquinone and mu-amine compositions
AU561106B2 (en) Diamidides and pyrethroids compositions
AU542682B2 (en) Polyether-silicone composition
AU7997382A (en) Haemobiologic composition
AU547650B2 (en) 4-carbamcyl-imidazolium-5-oleate compositions
AU539250B2 (en) Rtv-silicone composition
AU6038180A (en) Depalletisers and palletisers
AU545825B2 (en) Biphenylmethanols and derivatives thereof
AU543343B2 (en) Epoxy-imide composition

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired